Articles
Immune biomarkers in thymic epithelial tumors: expression patterns, prognostic value and comparison of diagnostic tests for PD-L1
Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer
Clinical significance of stromal ER and PR expression in periampullary adenocarcinoma
Cancer biomarkers for targeted therapy
Epigenetic heterogeneity in cancer
No hay comentarios:
Publicar un comentario